Marimed (MRMD) Price to Earnings (2012 - 2026)

Marimed (MRMD) has reported Price to Earnings for 15 consecutive years, with 7.86 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 60.02% year-over-year to 7.86 in Q2 2026; TTM through Jun 2026 was 1.88, a 10.62% decrease from a year earlier, with the FY2025 full-year figure at 2.47, up 32.9% from the prior year.
• Price to Earnings was 7.86 for Q2 2026 at Marimed, down from 7.41 in the prior quarter.
• Over five years, Price to Earnings peaked at 83.96 in Q2 2022 and troughed at 204.47 in Q1 2023.
• A 5-year average of 25.15 and a median of 9.11 in 2023 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings surged 157.06% in 2022 and slumped 454.01% in 2023, its largest moves.
• Over 5 years, Price to Earnings stood at 25.89 in 2022, then tumbled by 140.02% to 10.36 in 2023, then surged by 46.53% to 5.54 in 2024, then sank by 38.95% to 7.7 in 2025, then dropped by 2.17% to 7.86 in 2026.
• The last three Price to Earnings figures came in at 7.86 (Q2 2026), 7.41 (Q1 2026), and 7.7 (Q4 2025), per Business Quant data.